BML Capital Management, LLC - ARCA BIOPHARMA INC ownership

ARCA BIOPHARMA INC's ticker is ABIO and the CUSIP is 00211Y506. A total of 24 filers reported holding ARCA BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
BML Capital Management, LLC ownership history of ARCA BIOPHARMA INC
ValueSharesWeighting
Q3 2023$1,420,929
-1.0%
706,9300.0%1.30%
+1.1%
Q2 2023$1,435,068
+2.0%
706,9300.0%1.29%
+6.2%
Q1 2023$1,406,791
-30.8%
706,930
-17.6%
1.22%
-37.4%
Q4 2022$2,034,067858,2561.94%
Other shareholders
ARCA BIOPHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
Western Standard LLC 1,174,270$2,360,2832.13%
BML Capital Management, LLC 706,930$1,420,9291.30%
Newtyn Management, LLC 300,000$603,0000.15%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 46,948$94,3650.00%
OSAIC HOLDINGS, INC. 55$1100.00%
DIMENSIONAL FUND ADVISORS LP 42,514$85,4530.00%
Parallel Advisors, LLC 244$4900.00%
BANK OF AMERICA CORP /DE/ 31$620.00%
WELLS FARGO & COMPANY/MN 75$1510.00%
NORTHERN TRUST CORP 20,982$42,1740.00%
View complete list of ARCA BIOPHARMA INC shareholders